What is the BECOME collagen study?Updated 23 days ago
What is the BECOME collagen study?
Led by Dr Jenna Macciochi, Director of Science + innovation at Ancient + Brave, this gold-standard collagen clinical trial was designed to explore the efficacy of daily collagen - not just for skin, but for whole-body health.
Who took part?
This study took 12 weeks to complete and involved a midlife cohort of 90 healthy women aged 35-55. All had Fitzpatrick skin types, a healthy BMI, and visible signs of ageing.
Were controls made for participants' lifestyles?
Yes. No changes to diet, lifestyle, supplements or topical skin care were permitted during the study.
Which Ancient + Brave product did the study focus on?
This double-blind, randomised collagen study evaluated Ancient + Brave’s True Collagen (Type I, bovine, hydrolysed collagen peptides) vs. a placebo. This formula contains just one ingredient - pure hydrolysed collagen - demonstrating the power of collagen in its most simple, potent form.
To demonstrate the power of consistency, each participant took a 10g serving of True Collagen daily. For scientific rigour, this was tested against a placebo product in a real-world setting.
What did the BECOME collagen study prove?
This important collagen study demonstrated that True Collagen has proven benefits for skin, nail and hair strength in as little as 6 weeks. When taken consistently for 12 weeks or more, these benefits expand beyond skin to include supporting sleep, recovery and gut health, making collagen a comprehensive ally for whole-body wellbeing.
How long did it take to see results?
Participants were assessed at 6 and 12 weeks. By 6 weeks, 100% of participants reported signs of skin and hair improvement. By week 12, the benefits broadened to include joint comfort, sleep quality and energy levels.
Why is the BECOME collagen study significant?
Most collagen studies focus on the benefits of collagen for cosmetic concerns. The BECOME collagen study moves the evidence for collagen beyond this by evaluating collagen’s benefits across multiple areas of wellbeing, including digestion, exercise recovery and sleep.
How does the BECOME collagen study align with broader evidence?
The BECOME collagen study aligns with a growing body of evidence for the whole-body benefits of hydrolysed collagen peptide supplementation. This includes the Anglia Ruskin umbrella review, which evaluated 100 randomised controlled trials involving nearly 8,000 participants and concluded that collagen is a multi-beneficial supplement capable of supporting everything from skin health to joints, bone, muscle and more.
Will this clinical trial be registered?
It already is. The BECOME collagen clinical trial’s registration number is NCT06603194 and can be found at ClinicalTrials.gov.
Are there plans to publish the clinical trial data in a peer-reviewed journal?
Yes. This study adds an important layer to the existing collagen science, and plans to publish the data in a peer-reviewed journal are already underway.